Together with an observed upregulation of MIF-2 in unstable atherosclerotic plaques from CEA patients and a correlation of MIF-2 levels with the severity of CAD, our data suggest a role for MIF-2 in advanced atherosclerosis involving a dual lipid/hepatic and vascular phenotype. This evidence concerns the gene DDT and atherosclerosis.